Fate Therapeutics Appoints Edward Dulac as Chief Financial Officer
Go back to Fate Therapeutics Appoints Edward Dulac as Chief Financial Officer| FATE THERAPEUTICS (NASDAQ: FATE) | Delayed: 2.34 +0.04 (1.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.30 | 52 Week High | $4.76 | |||
| Open | $2.34 | 52 Week Low | $1.46 | |||
| Day High | $2.36 | P/E | N/A | |||
| Day Low | $2.31 | EPS | $-1.91 | |||
| Volume | 138,093 | |||||
